Literature DB >> 7774653

CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes.

C M Ausiello1, F Urbani, A la Sala, A Funaro, F Malavasi.   

Abstract

Human CD38 is a surface glycoprotein expressed by different immuno-competent cells such as immature and activated lymphocytes, plasma cells and natural killer cells. It has recently been reported that the CD38 molecule exerts adenosine diphosphate ribosyl cyclase activity and is associated with distinct transmembrane signaling molecules. This study reports that ligation of CD38 by specific monoclonal antibodies (mAb) induces multiple cytokine mRNA expression in cultured peripheral blood mononuclear cells (PBMC). The mRNA for tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-12 were always detected, whereas interferon-gamma and IL-10 mRNA expression were seen in most, but not all PBMC cultures. Low levels of IL-2, IL-4 and IL-5 mRNA were also found. The key observation of this work is that CD38 ligation in PBMC induces a large spectrum of cytokines, many of which overlap with those induced via CD3 activation. The main differences between CD38 and CD3 activation are the low to undetectable levels of IL-2 mRNA, and the sustained IL-1 beta and IL-6 mRNA accumulation found in PBMC cultures following treatment with anti-CD38 mAb. Furthermore, PBMC proliferation was not found to be a prerequisite for CD38-mediated cytokine induction. Together, these results suggest that human CD38 activates a signaling pathway which leads to the induction of a discrete array of cytokines, and that this pathway only partially overlaps with that controlled by T cell receptor CD3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774653     DOI: 10.1002/eji.1830250554

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Authors:  Sivasakthivel Thirugnanam; Pandurangan Pandiaraja; Kalyanasundaram Ramaswamy; Vadivel Murugan; Munirathinam Gnanasekar; Krithika Nandakumar; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Exp Parasitol       Date:  2007-03-06       Impact factor: 2.011

2.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.

Authors:  Subhashis Sarkar; Sachin K S Chauhan; John Daly; Alessandro Natoni; Heather Fairfield; Robert Henderson; Emma Nolan; Dawn Swan; Jinsong Hu; Michaela R Reagan; Michael O'Dwyer
Journal:  Cancer Immunol Immunother       Date:  2020-01-09       Impact factor: 6.968

Review 4.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

5.  CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation.

Authors:  Giorgio Fedele; Marco Di Girolamo; Umberto Recine; Raffaella Palazzo; Francesca Urbani; Alberto L Horenstein; Fabio Malavasi; Clara Maria Ausiello
Journal:  Mediators Inflamm       Date:  2013-12-30       Impact factor: 4.711

6.  Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.

Authors:  F R Donís-Hernández; R M Parkhouse; L Santos-Argumedo
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

Review 7.  CD38: T Cell Immuno-Metabolic Modulator.

Authors:  Anwesha Kar; Shikhar Mehrotra; Shilpak Chatterjee
Journal:  Cells       Date:  2020-07-17       Impact factor: 6.600

Review 8.  The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors.

Authors:  Jessica M Konen; Jared J Fradette; Don L Gibbons
Journal:  Cells       Date:  2019-12-24       Impact factor: 6.600

9.  CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.

Authors:  M T Zilber; S Gregory; R Mallone; S Deaglio; F Malavasi; D Charron; C Gelin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

10.  The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.

Authors:  Silvia Deaglio; Fabio Malavasi
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.